Quantitative Metabolomics and Its Application in Metabolic Engineering of Microbial Cell Factories Exemplified by the Baker’s Yeast by Mario Klimacek
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
2 
Quantitative Metabolomics and Its Application 
in Metabolic Engineering of Microbial Cell 
Factories Exemplified by the Baker’s Yeast 
Mario Klimacek 
Institute of Biotechnology and Biochemical Engineering, Graz University of Technology 
Austria 
1. Introduction 
The baker’s yeast Saccharomyces cerevisiae and its beneficial properties have been recognized 
very early by human beings. It has been used in the making of alcoholic beverages, bread 
and cake long before the term biotechnology has been coined. In addition to its great 
importance in food industry S. cerevisiae strains are nowadays applied in many other fields 
for example in the production of bio-fuels from corn or sugar containing crops, in the bio-
sorption of heavy-metals from sewage, in pharmaceuticals or in the production of precursor 
compounds for the synthesis of pharmaceuticals or fine chemicals. As a consequence S. 
cerevisiae developed to one of the most important and best investigated microbial cell 
factories for the industrial (white) biotechnology. Furthermore S. cerevisiae is an important 
model organism used to elucidate the underlying molecular mechanistic principles that are 
involved in complex diseases (cancer or diabetes) and metabolic disorders (Castrillo and 
Oliver 2005; Castrillo and Oliver 2006; Nielsen and Jewett 2008). Other important features of 
S. cerevisiae that led to its multifaceted applicability in industry and R&D constitute its 
GRAS (generally recognized as safe) status and that cells are very easy to cultivate and are 
readily available.  
The physiology of S. cerevisiae under various environmental conditions has been 
investigated intensively in the last 140 years (Racker 1974). The baker’s yeast exhibits 
some very interesting physiological features that render it unique among all other 
microorganisms. It grows nearly equally fast under aerobic and anaerobic conditions with 
glucose as the sole carbon source (Nissen et al. 2000a; Visser et al. 1990). Under aerobic 
conditions and at glucose concentrations above 100 mg/L biomass formation is 
accompanied by the production of ethanol as a consequence of an overflow metabolism at 
the pyruvate node (Crabtree-effect, (Crabtree 1928)). After depletion of glucose the 
ethanol initially formed by the overflow metabolism is further converted into biomass 
under aerobic conditions (Diauxie). Under anaerobic conditions about 90% of glucose 
carbon is converted into ethanol and CO2. The rate of glucose utilization and the specific 
ethanol yield is higher under anaerobic conditions as compared to the sugar conversion 
rate and ethanol yield under aerobic conditions (Pasteur-effect, (Racker 1974)). It can 
reduce a number of keto-compounds to the corresponding chiral alcohols that represent 
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interesting precursors for pharmaceuticals (Csuk 1991). It can grow as a diploid as well as 
a haploid which highly facilitates genetic manipulation and permits high-throughput 
genetic engineering.  
Considering the enormous early interest in studying and understanding the physiology of 
S. cerevisiae long before modern omics techniques have been developed, it is not very 
surprising that it was the baker’s yeasts genome that was the first within the domain of 
eukaryotes that was completely sequenced. Genomic and biological information about S. 
cerevisiae molecular biology is comprehensively collected at the Saccharomyces Genome 
Database (SGD, http://www.yeastgenome.org/). Driven by the knowledge of the 
complete genomic sequence and by the steadily increasing availability of tools developed 
for genetic engineering, S. cerevisiae became a key work horse and the representative 
eukaryotic model organism in every modern discipline within the biosciences such as 
molecular and cell biology, functional genomics, systems biology or metabolic and 
synthetic engineering. Today’s genetic work with S. cerevisiae cells is highly alleviated by 
the presence of a wide spectrum of established yeast molecular biology tool kits and 
availability of many wild-type and mutant strain (e.g. knock-out strains) collections as 
well as plasmid collections containing S. cerevisiae ORFs, gene deletion markers or 
promoter sets and many more, offered by commercial sources such as EUROSCARF 
(http://web.uni-frankfurt.de/fb15/mikro/euroscarf/index.html), Open biosystems 
(http://www.openbiosystems.com/Products/) or Addgene (http://www. addgene. 
org/).  
The commercial establishment of genetic manipulation techniques paved the way for S. 
cerevisiae to be exploited in the field of metabolic engineering. Various novel recombinant 
designer strains capable of either selective formation of one desired product or of producing 
heterologous compounds or endogenous products from new resources (waste or renewable 
materials) emerged in the last decades. Metabolic engineering efforts based on S. cerevisiae 
are comprehensively summarized elsewhere and the interested reader is referred to (Bettiga 
et al. 2010; Nevoigt 2008). A collection of engineered substrate utilization and heterologous 
or homologous product formation pathways is given in Table 1.  
The corresponding underlying engineering principles can be basically broken down into 4 
strategies as depicted in Figure 1 panel A-D. Elucidation of the appropriate engineering 
approach represents the most important step in designing novel cellular properties and 
targets on the identification of reaction(s) or even entire pathways that are suited for the 
anticipated metabolic engineering objective. Relevant reaction(s) and associated gene(s) can 
be extracted by thorough screenings of literature data (US National Library of Medicine 
(http://www.ncbi.nlm.nih.gov/pubmed), SciFinder (https://scifinder.cas.org/) or Web of 
Knowledge (http://wokinfo.com/)) and online databases (KEGG the Kyoto Encyclopedia 
of Genes and Genomes (http://www. genome.jp/kegg/), the enzyme database BRENDA 
(http://www.brenda-enzymes.org/), or the SIB bioinformatics Resource Portal ExPASy 
(http://www.expasy.ch/). 
To increase the probability of engineering success identified targets can be subjected to in 
silico modeling by employing mathematical models like restricted flux balance analysis 
(FBA) based on a genome-scale stoichiometric network to verify their compatibility with the 
underlying metabolic network (Cvijovic et al. 2010; Selvarajoo et al. 2010). 
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Substrate targets Applications References 
Xylose bio-ethanol  
(Jeffries and Jin 2004; 
Petschacher and Nidetzky 
2008; van Maris et al. 2007) 
L-Arabinose bio-ethanol  (Wisselink et al. 2007) 
Lactose / whey bio-ethanol (Domingues et al. 2010) 
Galactose bio-ethanol (Lee et al. 2010) 
   
Product targets   
   
Insulin and insulin 
precursors pharmaceuticals  (Kjeldsen 2000) 
Hepatitis B antigen pharmaceuticals (Kuroda et al. 1993) 
Cyanophycin biopolymer (Steinle et al. 2009) 
Organic acids chemical building blocks (Abbott et al. 2009; Ishida et al. 2006; Raab et al. 2010) 
n-Butanol bio-fuel (Steen et al. 2008) 
Sesquiterpenes pharmaceuticals and food (Asadollahi et al. 2010; Jackson et al. 2003) 
Carotenoids pharmaceuticals and food  (Ukibe et al. 2009) 
Diterpenoids pharmaceutical industry (Dejong et al. 2006) 
Triterpenes pharmaceutical industry (Madsen et al. 2011) 
Polyketides pharmaceutical industry (Mutka et al. 2006) 
Five-carbon sugars / 
alcohols food ingredients (Toivari et al. 2007) 
Ethylene synthetic polymers (Pirkov et al. 2008) 
Flavonoids, stilbenoids pharmaceuticals and food (Trantas et al. 2009) 
SO2 beer flavor stability (Yoshida et al. 2008) 
Ethanol bio-fuel (Nissen et al. 2000b) 
Table 1. Collection of metabolic engineering targets in S. cerevisiae 
To unravel reaction(s) or pathways instead that would compromise substrate conversion 
and/or production of a desired product in silico modeling by for example FBA (Bro et al. 
2006) or MOMA (minimization of metabolic adjustment) (Asadollahi et al. 2009) have been 
applied and produced potential candidate reactions which otherwise would have been often 
overlooked (Cvijovic et al. 2010). The open-source software platform OptFlux developed 
especially for in silico driven metabolic engineering is available at http://www.optflux.org/ 
(Rocha et al.).  
Metabolic integration of a novel pathway is selected when the utilization of a new substrate 
(Fig. 1 A) or synthesis of a new product is intended (Fig. 1 B). New in this context means 
that the original, not engineered, cells are genetically not programmed to perform these 
reactions. Formation of an undesired side-product (Fig. 1 C) can be attributed to a split in 
carbon flux at the related node (C) into a productive (CP) and undesired flux (CD). 
Reasons for such flux partition compromising efficient production of the product (P) can be 
often traced back to the presence of an enzyme or differently regulated isoenzyme 
competing for the same substrate S or a promiscuous enzyme that in addition to the desired 
substrate is also active with other substrates (Fig. 1 D). 
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Fig. 1. Typical metabolic engineering principles based on rational design (panels A – D) are 
linked to a suggested experimental work-flow to unravel limiting metabolic sites. Panels A-
D refer to enabling of substrate utilization (A) or product formation (B), preventing  side 
product formation by deletion and/or overexpression of an endogenous enzyme (C), 
increasing selectivity of a substrate promiscuous enzyme (D); Substrate A, intermediate B, 
product P and enzymes E new to the network are indicated in grey. Overexpression of an 
endogenous enzyme is depicted by a grey e. Knock outs are indicated by grey x’s. Subscripts 
of rate constants v given as numbers and small letters refer to fluxes based on stoichiometry 
(solid arrows) and individual reaction rates of enzymes (dotted arrows), respectively.  
Directing the carbon flux towards P can be afforded by deletion of respective gene(s), 
overexpression of enzymes participating in the productive branch, or replacing the 
corresponding activity by a less regulated or more selective one. Furthermore unbalanced 
carbon usage between reaction partners participating in this pathway and/or in the 
recycling of, for example cofactors, can result in accumulation and release of a pathway 
intermediate (Krahulec et al. 2009; Krahulec et al. 2010). In this case fine-tuning of all 
activities involved based on for example a metabolic control analysis (MCA) or kinetic 
modeling analysis is required to minimize or even completely prevent by-product 
accumulation (Parachin et al. 2011).  
Aside from rational design stochastic methods based on inverse metabolic engineering  have 
been developed for S. cerevisiae to identify key target reactions and associated gene 
sequences enabling the desired new cellular property (Bailey et al. 2002; Bengtsson et al. 
2008; Bro et al. 2005; Hong et al. 2010; Jin et al. 2005; Lee et al. 2010). Differently, methods 
targeting on the induction of a cellular property, such as growth, increase of substrate 
conversion rate or enhancing resistance to environmental stress, that is hardly to capture by 
in silico design because of its highly intricate metabolic relations that have to be satisfied, 
rely on the cellular adaptability to a certain environmental stress by evolution (Cakar et al. 
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2009; Cakar et al. 2005; Garcia Sanchez et al. 2010; Kuyper et al. 2005; Sonderegger and Sauer 
2003; Wisselink et al. 2009).  
In the course of establishing systems biology various high-throughput omics techniques such 
as transcriptomics, proteomics, fluxomics and others have been developed with the objective 
to comprehensively analyze cellular physiology at all molecular levels (DNA, RNA, protein, 
flux, and metabolite). Data-driven analysis is often exploited to unravel novel interrelations at 
the various molecular levels or to obtain a more insightful (quantitative) understanding of 
cellular processes. It is obvious that metabolic engineering can greatly benefit from the 
integration of omics techniques in the design of improved microbial cell factories (Nielsen and 
Jewett 2008). The various omics tools have helped to increase understanding about how cells 
regulate, communicate and adapt to different environmental conditions.  
Depending on the metabolic engineering objective the appropriate omics tool or a 
combination should be selected after due consideration. For example transcriptome analysis 
provides a holistic image of mRNA molecule pattern and levels but do not tell us anything 
about metabolic fluxes. Optimization of the flux towards a specific metabolite however 
represents one of the major goals in metabolic engineering. Metabolic flux analyses based on 
stoichiometric models or 13C-isotopomer analysis (provided that cells can grow under the 
environmental conditions used) are useful tools in this respect (Nielsen and Jewett 2008). To 
understand the underlying mechanistic relationships between the flux through a particular 
pathway and the enzymes forming the pathway, providing the relevant information for 
strain design, detailed knowledge about enzyme-metabolite interactions are required. 
Consequently quantitative information about metabolites involved together with detailed 
knowledge of kinetic properties of participating enzymes is mandatory. Within the omics 
family metabolomics represents the youngest member. This is basically due to the facts that 
metabolites vary greatly in their physico-chemical properties (polarity, acidity, reactivity, 
and stability) and are present in a large dynamic concentration range which make it almost 
impossible to record the entire metabolome on a single analytical platform. Another 
challenge represents the generation of reliable and representative metabolite data from 
biological samples. Cell-wall leakage, instabilities and losses of metabolites throughout the 
sample work-up, or strong matrix effects in the MS analysis are a few of the many causes 
impairing metabolite data and as a consequence adulterate molecular mechanistic 
interpretation. Nevertheless in the last years much progress has been made due to 
enormous efforts of the yeast research community to overcome these obstacles. Protocols of 
unbiased sample-work-up and different analytical platforms are available today that can 
cover more than 100 compounds quantitatively.  
This review presents current accepted protocols and techniques that enable acquisition of 
absolute quantitative metabolite data from S. cerevisiae cells. The second part focuses on how 
quantitative metabolite data can help in the development of improved microbial cell factories. 
However, before going into the details some definitions of terms used in metabolome 
analysis should be reminded (Nielsen 2007). Metabolite profiling targets on the qualitative 
or semi-quantitative analysis of specified metabolites or groups of metabolites. In contrast in 
metabolite target analysis selected metabolites are quantified. If the entire metabolome or a 
fraction of it is addressed (or as many metabolites as possible) qualitatively or quantitatively 
we speak of metabolomics or quantitative metabolomics.  
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2. Data acquisition for quantitative metabolomics in Saccharomyces 
cerevisiae 
Determination of unbiased intracellular concentrations of metabolites is without doubt a 
prerequisite for serious interpretation of cellular properties at the molecular – kinetic level. 
Unbiased refers here to the physiological state, the sample work-up and preparation for 
metabolite analysis and metabolite quantification and calculation of intracellular molar 
concentration. Consequently four experimental tasks that have to be fulfilled can be 
formulated as follows: 
 Harvesting and quenching of cells at a predefined physiological state (representative) 
and separation from extracellular compounds (exometabolome) without leakage of 
intracellular metabolites (quantitative) 
 Destruction of metabolic activity and complete extraction of metabolites by maintaining 
the metabolite composition quantitatively unchanged, concentration and if required 
chemical preparation for metabolite analysis 
 High-throughput quantitative analysis by employing the appropriate instrument  
 Relation of molar concentrations obtained from quantitative analysis to cell specific 
parameters such as cell dry weight (µmol / gCDW) or cell number (µmol / cell) or if 
absolute molar intracellular concentrations are required to the cell (compartment) 
volume. 
However, before we go into the details and hurdles of each task it should be emphasized 
here that altering the cellular network by metabolic engineering will always result in a quasi 
new strain with completely new properties and behaviors. In the worst case the complete 
sample work-up protocol established for the wild-type strain might not be applicable for the 
mutant strains. It is therefore strongly recommended that protocols already established for 
the absolute quantification of metabolites have to be re-assessed and verified for the created 
strains. 
2.1 Representative harvesting and quantitative quenching 
The concentration of a metabolite in the cell is not directly linked to genes but is determined by 
its formation and utilization rates. Conversion rates in turn depend on the enzymes associated 
catalytically with this metabolite and their kinetic parameters with respect to this metabolite as 
well as effectors (inhibitors, activators). In particular metabolites from catabolic reactions and 
reactions involved in energy metabolism display high turnover rates. For example for the 
frequently used metabolite ATP (~16% of all reactions present in a genome-scale 
stoichiometric model of S. cerevisiae involve ATP (Förster et al. 2003)) turnover rates of ~1.5 
mM/s were reported (Rizzi et al. 1997). Hence, quenching of metabolic activity within a very 
short time window is required without altering the metabolomic state of the sample. Another 
highly desirable feature is that the extracellular environment containing substrates, products, 
salts and the exometabolome, that can affect subsequent metabolite analysis, is separable from 
the cells without losing any intracellular metabolites due to disruption of or leakage through 
the cell wall. Different to for example E. coli the cell wall of S. cerevisiae is less leaky and both 
requirements can be achieved for S. cerevisiae cells by spraying a defined volume of cell 
suspension into an appropriate quenching solution at sufficiently low temperatures. It was 
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found that the volume ratio of sample to quenching solution affects the quenching quality and 
a ratio of at least 1 to 5 was suggested (Canelas et al. 2008a).  
Today two methods cold methanol and cold glycerol-saline have achieved wide 
acceptance within the metabolomics community (Canelas et al. 2008a; Villas-Bôas and 
Bruheim 2007). See Fig. 2 for details. In addition to the quenching temperature and time 
or the volume ratio between sample and quenching solution, the time between 
quenching and separation by centrifugation and the centrifugation time can influence 
metabolic activity and metabolite leakage significantly. Harvesting by rapid sampling is 
often coupled to quenching. Rapid sampling is especially important in continuous 
steady-state cultivations and for pulse-experiments in which changes of intracellular 
metabolite pools induced by a certain environmental impulse are analyzed at the sub-
second time scale. Ingenious devices have been developed in the last years that enable 
rapid sampling and quenching simultaneously at the millisecond scale. The various 
manual, semiautomatic and fully automatic rapid sampling techniques and their pros 
and cons have been comprehensively discussed and the reader is referred to (Reuss et al. 
2007; van Gulik 2010; Villas-Bôas 2007a). A disadvantage in this context is that most of 
these devices are not available on the market and therefore not accessible to the scientific 
community. Commercial accessibility however would be of great importance in the 
context of comparability, reproducibility and standardization in quantitative 
metabolomics studies. In batch cultivations manual transfer of the cell suspension to the 
quenching solution by using a pipette or a syringe is widely accepted as environmental 
conditions might not change significantly during the sample transfer (3 – 6 s) (Villas-
Bôas 2007b). These assumptions might hold for anaerobic or microaerobic conditions but 
should be reconsidered in case of aerobic cultivations for which for example the O2/CO2 
ratio may vary and induces changes (oxygen limitation) in cell metabolism during 
sampling.  
2.2 Quantitative metabolite extraction 
The next challenge represents the quantitative extraction of all metabolites or at least of 
those to be of interest without reactivating any metabolic activity, enabling chemical 
reactions and minimizing metabolite disruption. Metabolic activity and chemical reactions 
can be controlled by the temperature. The addition of a denaturing (inactivating) agent 
bears some risks as it might be also reactive with metabolites or provides the environment 
(pH) for chemical reactions (Villas-Bôas 2007b). Control of metabolite degeneration or 
reactivity during extraction and in the following process steps represents a complex and 
difficult task. Furthermore metabolite degeneration is a highly specific process and 
strongly depends on the metabolite species, extraction solution and extraction parameters 
(pH, T). For example the redox cofactors NAD+ and NADP+ are stable at acid to neutral 
pH even at high temperatures (80-90°C) for 3 minutes (Klimacek et al. 2010). On the 
contrary their reduced counterparts are highly unstable under acidic conditions with 
NADPH generally less stable than NADH (Chaykin 1967; Lowry et al. 1961). At high pH 
where NAD(P)H are stable NAD(P) in turn destruct rapidly (Lowry et al. 1961). 
Decomposition can also be catalyzed by phosphate a prominent compound in metabolite 
extracts (van Eunen et al. 2010) by forming an adduct with NADH across the pyridine 
group (Alivisatos et al. 1964; Chaykin 1967). 
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Fig. 2. Collection of state-of-the-art protocols for leakage-free quenching and quantitative 
extraction. Relevant literature and details can be found in the text. 
It is obvious from this example considering just four metabolites that the ideal extraction 
procedure with which the complete metabolite consortium is extractable without any losses 
may not exist and calls for a compromise in the selection of conditions used for metabolite 
extraction. This “inconvenience” however can be circumvented, provided that subsequent 
metabolite detection is based on mass spectroscopy, by the addition of an aliquot of U-13C-
labled internal standard (IS) compounds to the biomass subsequent to quenching or prior to 
metabolite extraction (Büscher et al. 2009; Canelas et al. 2009; Klimacek et al. 2010; Mashego 
et al. 2004; Wu et al. 2005). Metabolite losses due to incomplete quantitative work-up of 
samples can be addressed by application of one selected IS compound. However metabolite 
specific instabilities, matrix effects, ion suppression, non-linear responses and day-to-day 
variations can be only identifed and appropriately corrected for by the addition of U-13C-
labled IS. A representative mixture of labeled metabolites can be easily prepared from S. 
cerevisiae wild-type and/or mutant cells cultivated in standard mineral medium 
supplemented with U-13C-labled substrate (glucose, fructose, galactose,…) under the 
cultivation condition selected and by respective appropriate quenching and extraction 
procedures. Internal referencing by using an IS displaying a metabolite composition that is 
representative for the cellular state to be studied should be always taken into account 
because intracellular metabolite levels can vary considerably in dependence on the 
cultivation conditions used or on the cellular alterations introduced by pathway engineering 
(Klimacek et al. 2010).  
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Various extraction protocols with respect to extraction solvent (acids, bases, ethanol or 
methanol, organic solvents), buffered or non-buffered solutions, pH, temperature, etc have 
been tested (Villas-Bôas 2007b), evaluated and verified for S. cerevisiae cells in terms of 
metabolite coverage, efficacy and recovery (Klimacek et al. 2010) in the last years (Canelas et 
al. 2009; Villas-Bôas et al. 2005b). Today three extraction procedures have achieved some 
acceptance and are likewise used within the yeast research community (see Fig. 2 for 
details). That is boiling ethanol (BE; pioneered for S. cerevisiae cells by (Gonzalez et al. 1997)), 
chloroform-methanol (CM; pioneered for S. cerevisiae cells by (de Koning and van Dam 
1992)) and to some extent freeze-thawing in methanol (FTM; pioneered for S. cerevisiae cells 
by (Villas-Bôas et al. 2005b) for which however controversial results with respect to its 
applicability are present in the literature. While (Villas-Bôas et al. 2005b) found extraction 
performance of FTM sufficient, others (Canelas et al. 2009) concluded that FTM cannot 
effectively prevent metabolite conversion throughout the extraction process and considered 
FTM therefore as not appropriate for metabolite extraction. Differences in evaluation criteria 
and growth conditions were used as a basis to explain the different outcomes. It should be 
however noted that (Canelas et al. 2009) investigated metabolite extraction performances 
from S. cerevisiae cells grown under two different physiological conditions (glucose 
limitation and glucose saturation; a bioreactor coupled to a rapid sampling device was 
used), used identical U-13C-labled compounds as IS and three different analytical methods 
for quantification of a broad range of different compounds. Quality and metabolite recovery 
of FTM instead was judged by (Villas-Bôas et al. 2005b) by the application of an IS mixture 
composed of compounds each a representative for a substance class analyzed. The mixture 
was added to the quenched cells prior to extraction. Cells were cultivated under aerobic 
conditions in shake flasks and metabolites were quantified by established GC-MS after 
metabolite derivatization with methyl chloroformate. In Fig. 2 brief descriptions of 
respective protocols are compiled. A broad spectrum of compounds covering a wide range 
of different chemical properties such as acidity, polarity, size and responsiveness can be 
addressed with either of these extraction protocols. Details with respect to extraction 
method specific component coverage can be extracted from (Buescher et al. 2010; Büscher et 
al. 2009; Canelas et al. 2008a; Canelas et al. 2009; Klimacek et al. 2010; Villas-Bôas and 
Bruheim 2007; Villas-Bôas et al. 2005b). 
2.3 Quantification of intracellular metabolites 
Approximately 600 metabolites are present in S. cerevisiae cells and their concentrations 
range from sub-µM to mM (Nielsen 2007). Their levels vary considerably in dependence on 
the environmental conditions applied or mutation introduced. Hence analysis tools suited 
for the determination of intracellular metabolites should be able to cover quantitatively as 
many metabolites as possible in wide concentration ranges.  
Early studies that have focused on analyzing intracellular metabolites used enzymatic 
assays (Ciriacy and Breitenbach 1979; de Koning and van Dam 1992; Gonzalez et al. 1997; 
Grosz and Stephanopoulos 1990; Kötter and Ciriacy 1993; Theobald et al. 1997) or NMR 
analysis (den Hollander et al. 1981; Navon et al. 1979; Shanks and Bailey 1988) for 
quantification of a few compounds present in the cell. To increase the coverage towards a 
holistic quantitative record of the endometabolome enormous efforts were put on the 
development of new methods and techniques in the last years. In particular mass 
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spectrometry revealed to be excellently suited in this respect and analytics of metabolite 
targeting switched therefore from an enzyme assay- or NMR-based to a mass spectrometry-
based technique. Today three platforms dominate the analytical part of metabolomics. That 
is mass spectrometric detection in the form of a single, tandem or triple quadrupole or 
orbitrap mass spectrometer (MS) coupled via an electrospray ionization source (ESI) to a 
component separation device such as gas chromatography (GC), reverse-phased ion-pairing 
or anion exchange liquid chromatography (LC) or capillary electrophoresis (CE). Cross-
platform comparison with respect to quantitative metabolomics revealed LC as the best 
suited separation technique for analysis on a single platform in terms of versatility and 
robustness. It was suggested by the authors that it is best complemented by the use of the 
GC platform (Büscher et al. 2009). More than 100 metabolites could be successfully 
quantified by GC-MS (~100 metabolites, (Villas-Bôas and Bruheim 2007; Villas-Bôas et al. 
2003; Villas-Bôas et al. 2005b; Villas-Bôas et al. 2005c)), reverse phase ion pairing LC coupled 
to a triple quadrupole (138 metabolites, (Buescher et al. 2010)) or an orbitrab mass spec (137 
metabolites, (Lu et al. 2010)). Especially the LC-MS platform has been investigated 
intensively with respect to quantitative metabolite coverage, sensitivity and robustness and 
revealed to be very suited for the comprehensive analysis of the central carbon metabolism 
(Buescher et al. 2010; Büscher et al. 2009; Lu et al. 2010). Almost all metabolites involved in 
glycolysis, pentose phosphate pathway and TCA cycle could be addressed. In addition 
amino acids and their precursors, redox cofactors, nucleotides, coenzyme A esters and many 
more can be analyzed in one sample run in approximately half an hour (Buescher et al. 2010; 
Lu et al. 2010). Current LC-techniques used in metabolomics are however limited to water 
soluble analytes (Buescher et al. 2010).  
As mentioned above absolute quantification of intracellular metabolites is indispensably 
linked to the use of U-13C-labled internal metabolite standards. Consequently the number 
of compounds to be analyzed doubles which makes data analysis more demanding. 
Residual amounts of substrates, products and ionic components in the labeled and 
unlabeled metabolite extracts can significantly alter the elution profile and ionization 
characteristics of compounds analyzed (Buescher et al. 2010). These so called matrix 
effects are hardly to predict and are typically experienced as an increase of the base line 
signal associated with a high signal-to-noise ratio and as shifts in metabolite-specific 
retention times. Consequently peak-to-peak resolution and base line separation of peaks 
can become badly affected. Exacerbate and tedious manual peak integration is in these 
cases required. Alternatively complex often erroneous peak deconvolution algorithms are 
applied. To reduce matrix effects to a minimum demands preparation of “clean” - 
meaning free of disturbing media compounds - metabolite extracts for both biological 
samples and IS.  
The recommended procedure for internal referencing by identical U-13C-labled compounds 
involves addition of a defined volume of IS to the biological sample (prior to extraction) and 
to all analytical standard dilutions (minimum 6 dilutions). A standard mixture containing all 
the compounds at known concentrations to be analyzed is commonly used. As some 
metabolites are not very stable it is recommended to store a master mixture containing just 
the stable compounds and add the sensitive components prior to analysis. Metabolites are 
quantified by comparing the ratio of 12C- to 13C- signals with the 12C/13C signals of the 
representative standard compounds.  
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2.4 Calculation of molar intracellular metabolite concentrations 
The ultimate goal of quantitative metabolomics is the presentation of intracellular 
metabolite pools in the form of absolute molar concentrations. Only the knowledge of molar 
concentrations enables reliable integration of metabolome data in thermodynamic analysis, 
application in MCA based on fundamental enzyme kinetics or kinetic modeling. In the last 
step of absolute quantification of intracellular metabolite pools, the unbiased molar 
concentrations of metabolites obtained by the methods described above have to be therefore 
somehow related to the cell volume. For this reason metabolite concentrations and cell 
volume are based on the cell dry weight (CDW) producing specific parameters for 
metabolite concentrations in µmol/gCDW (= [metabolite]*volume of metabolite extract / 
([dry cells]*volume of biological sample)) and for the cell volume in mL/gCDW. By 
dividing these parameters the intracellular metabolite concentration in mM is eventually 
obtained. Hence accurate determination of the CDW and cell volume is mandatory for 
calculation of reliable intracellular metabolite data and for molecular mechanistic 
interpretation relying on this data. Different methods can be found in the literature. Briefly, 
first the physiological state has to be specified at which the CDW should be analyzed. 
Second an aliquot of cell suspension is separated from the medium by vacuum filtration or 
centrifugation. The cell pellet is washed with ice-cold water or physiological NaCl solution 
to remove residual medium components and subsequently dried at 100-105°C until 
constancy of mass is verified. One should however keep in mind that application of NaCl 
can compromise resulting CDW values significantly when low amounts of biomass are 
addressed. The volume of S. cerevisiae cells at a particular physiological state can be 
determined by applying a Coulter counter analyzer or by microscopic techniques (Lord and 
Wheals 1981; Tamaki et al. 2005).  
The cell volume of the baker’s yeast was found to depend on the growth conditions and 
environmental parameter settings and can vary considerably. For example, the cell volume 
varies by a factor of 2-3 (16 – 42 µm3) with doubling time (Lorincz and Carter 1979; Tyson et 
al. 1979) and the type of substrate metabolized (Johnston 1977; Tamaki et al. 2005). The 
lower the doubling time the larger the cells (Tyson et al. 1979). Cells grown on  glucose, the 
most favored carbon source, are larger than those grown on a nonfermentable carbon source 
(Johnston et al. 1979; Lorincz and Carter 1979; Porro et al. 2003; Tyson et al. 1979). Cells 
cultured in the presence of ethanol showed an enlarged size (Kubota et al. 2004). In contrast 
nitrogen starved cells are abnormally small (Johnston 1977). The level of 
repression/derepression also contribute significantly to the cell size (Mountain and Sudbery 
1990). Interestingly therefore that on the basis of the more relevant parameter for 
quantification the specific cell volume, S. cerevisiae cells do not show significant variation 
with the growth rate (Brauer et al. 2008) and values in the range of 1.5 – 1.9 mL/gCDW can  
be found in the literature for the strain CEN.PK 113-7D (Canelas et al. 2011; Cipollina et al. 
2008; van Eunen et al. 2009). A slightly higher value of 2.38 mL/gCDW has been reported 
for another strain CBS 7336 (ATCC 32167) (Ditzelmüller et al. 1983). We can conclude that 
although the cell volume is highly sensitive to conditions applied the specific cell volume is 
rather constant. Nevertheless a 1.6-fold higher specific cell volume results in likewise lower 
metabolite concentrations which in some cases (e.g. [substrate] < Km) may have an influence 
on the data interpretation. In the light of metabolic engineering it is hard to predict whether 
this “constant” likewise translates to recombinant cells. For example S. cerevisiae cells 
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adapted to high ethanol concentrations displayed an altered cell size (Dinh et al. 2008). Or 
overexpressing mannitol-1-phosphate dehydrogenase (M1PDH) in S. cerevisiae to produce 
mannitol from glucose caused a substantial increasing of the size of cells (Costenoble et al. 
2003). 
As for all eukaryotic organisms S. cerevisiae metabolism is compartmented (cytosol, 
mitochondrion, vacuoles) which poses a problem for the accurate determination of 
concentrations of relevant intracellular metabolites. Current techniques for extracting 
metabolites and isolating organelles do not allow for absolute separation from the cytosol 
without altering the respective metabolite composition and pattern. Indirect strategies based 
on metabolic engineering or on fundamental thermodynamic principles have been 
developed to address this obstacle and gave first preliminary and semi-quantitative insights 
into the distribution of metabolites between cytosol and mitochondrion.  
Functional expression of M1PDH from E. coli in S. cerevisiae was used as indicator reaction to 
determine the cytosolic free NAD to NADH ratio (Canelas et al. 2008b). M1PDH catalyzes the 
reversible NAD(H)-dependent interconversion of fructose 6-P (F6P) and mannitol 1-P (M1P). 
This reaction is directly connected to the central carbon metabolism and represents a dead-end 
reaction in the metabolism of yeast under the conditions applied in this study. Based on the 
assumption that the M1PDH reaction is at equilibrium the authors were capable of calculating 
the NAD/NADH ratio from the equilibrium constant and the intracellular concentrations of 
F6P and M1P. Data were verified by thermodynamic analysis. The cytosolic ratio of 
NAD/NADH was found to be ~10-fold higher as compared to the same ratio when based on 
the whole cell. Under anaerobic conditions however mannitol is formed from M1P implying 
that this approach is not yet universally applicable (Costenoble et al. 2003). 
A different approach based on a network-embedded thermodynamic analysis later termed 
anNET (Zamboni et al. 2008) was used by (Kümmel et al. 2006) to resolve 
intracompartmental feasible concentration ranges from cell-averaged metabolome data.  
Although these first results are promising there is large open space for the development of 
novel strategies combined with appropriate experimental techniques that enable precise 
compartment-specific quantification.  
3. How can metabolic engineering of S. cerevisiae benefit from quantitative 
metabolomics? 
In the typical metabolic engineering approach a bunch of new recombinant strains are 
designed and created with respect to a particular objective (see Fig. 1) or obtained from 
evolutionary adaption. Their new phenotypes are tested by fermentation or conversion 
experiments from which the substrate uptake rate and the product pattern in the form of 
specific product yields are determined. Results are often applied to FBA for verification. 
Intracellular enzyme activities of the introduced reactions as well as of those catalyzing 
reactions relevant for the new phenotype are measured from cell-free extracts. This data set 
usually provides many valuable details about the production efficiency in terms of 
conversion rate (how do intracellular activities of target enzymes compare to the conversion 
rate measured) and product selectivity (identification of side-products and oftentimes the 
reactions or pathways involved).  
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So how do metabolomics and more specifically quantitative metabolomics come into play? As 
described above the composition of intracellular metabolites together with their levels represent 
a direct signature of the physiological state of the cells investigated. Comparing metabolite 
profiles of wild-type and mutant strain(s) was often used to identify target reactions limiting the 
conversion rate (Hasunuma et al. 2011; Kahar et al. 2011; Klimacek et al. 2010; Kötter and 
Ciriacy 1993; Wisselink et al. 2010; Zaldivar et al. 2002) or extract the metabolite pattern 
representative for the new phenotype (Canelas et al. 2008b; Devantier et al. 2005; Ding et al. 
2010; Hou et al. 2009; Kamei et al. 2011; MacKenzie et al. 2008; Pereira et al. 2011; Raamsdonk et 
al. 2001; Ralser et al. 2007; Thorsen et al. 2007; Usaite et al. 2009; Villas-Bôas et al. 2005a; Villas-
Bôas et al. 2005c; Yoshida et al. 2008). Even apparently silent phenotypes of S. cerevisiae single 
deletion mutants can be uncovered with respect to the underlying mutation based on the 
developed metabolome (Raamsdonk et al. 2001). The rate however at which a compound’s 
carbon skeleton is channeled through a certain pathway is directly linked to the level of active 
enzymes present and their affinity to the participating reactants as well as to fundamental 
thermodynamic laws of the reactions involved. Consequently knowledge about intracellular 
concentration of metabolites and enzyme activities combined with thermodynamic and enzyme 
kinetic analysis can provide novel and valuable insights into the kinetic organization of the 
engineered pathway or even the associated metabolic network which eventually exposes key 
regulatory or flux limiting sites. Differently to the general holistic approach usually found in 
systems biology pathway analysis in metabolically engineered cells can be reduced in most 
cases to the components involved in the new pathway and those connecting this pathway to the 
central carbon metabolism (Parachin et al. 2011).  
3.1 Thermodynamic pathway analysis 
If we are interested in analyzing a pathway or network of pathways on the basis of 
thermodynamic rules with the aim to extract pathway or network relevant mechanistic 
relationships, knowledge of exact quantitative metabolite data of all reactants involved is 
mandatory. On the contrary we can also check quantitative metabolome data with respect to 
its thermodynamic consistency (Kümmel et al. 2006) but most importantly we can get first 
hits of potential candidate reactions for metabolic engineering within a metabolic network 
without any knowledge about enzyme activity and kinetic parameters. Consider the 
following reaction 
 A + B  C + D (1) 
The chemical equilibrium constant (Keq) associated with this reaction can be defined 
according to the law of mass action as 
 Keq = cCeqcDeq/(cAeq cBeq)     (2) 
The superscript eq relates to the concentrations c of reactants at the chemical equilibrium. 
The standard Gibbs energy of a chemical reaction (rG0, usually given in J/mol) is related to 
Keq by the fundamental relationship 
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in which vi and fGi0 correspond to the stoichiometric coefficient of reactant i and to the 
standard reaction Gibbs energy of formation of species i at a specified T, P and ionic 
strength, respectively. R and T denote the general gas constant (8.314 J/mol/K) and absolute 
temperature in Kelvin (K), respectively. The Gibbs energy of formation of a reactant i (fGi) 
is further defined by  
 fGi = fGi0 + RT ln(ci) (4) 
ci in Equation (4) refers to the concentration of reactants involved. The Gibbs energy of a 
reaction eventually is described by  
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Q in Equation (5) indicates the reaction quotient cC cD / (cA cB), which is also known under 
the term “mass action ratio” that is frequently abbreviated by Γ. Rearranging Equation (4) 
yields 
 rG = RT {ln(Q/Keq)} (6) 
Now the reaction in Equation (2), reading from the left to the right, takes place freely in the 
forward direction A,B  C,D at rG < 0 (Keq > Q), is at equilibrium and displays no net flux 
when rG = 0 (Keq = Q) and needs support by an external driving force when rG > 0 (Keq < 
Q). In other words the reverse reaction is favored under these Q-conditions implying a net 
flux in the back direction, C+D  A+B. Equation (6) therefore provides a very convenient 
and important expression that permits immediate assignment of the net flux state of a 
reaction within a pathway or a large metabolic network provided that Keq and all reactants 
participating in the particular reaction are known. The value of Keq is dependent on the 
temperature, the ionic strength and the pressure (Alberty 2003). As a consequence only 
those Keqs should be applied that were determined under conditions representative for the 
cell’s physiological state investigated. In particular temperature, ionic strength and pH are 
of considerable interest as pressure can be in most cases assumed as a constant. Thereof only 
the temperature during the cultivation experiment, that is usually 30°C for S. cerevisiae, is 
known. Unfortunately most Keqs tabulated have been determined at 25°C. For S. cerevisiae 
cellular ionic strength and pH are often assumed to be 0.1 M and 7.0, respectively. This may 
be sufficient for many thermodynamic network analyses. The validity of these assumptions 
however should be tested in any event prior pathway or network analysis. Algorithms are 
available that allow to some extent compensation for ionic strength and temperature.  
Equilibrium constants can be determined by three different methods based on either in vitro 
assay with isolated enzymes, compound-specific standard Gibbs energy of formation (see 
Equation (3)) or in vivo experiments that combine FBA with quantitative metabolomics.  
In case of using an isolated enzyme a reaction assay is designed such that known 
concentrations of substrate(s) and product(s) are solved in a buffer with defined ionic 
strength and pH. The reaction is started by the addition of the enzyme and processed at a 
certain temperature as long as the equilibrium state is reached. Reactant concentrations are 
then analyzed by appropriate techniques and the apparent Keq (K’eq) at a specified pH, ionic 
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strength and temperature is calculated with respect to the underlying stoichiometry of the 
reaction. Values for K’eq are usually applied in the context of network analysis. Importantly 
all reactants and the enzyme must be of highest purity and must be stable along the time of 
incubation. The composition of the reaction mixture at the equilibrium must not change in 
the subsequent component analysis.  
When the fGi0 for all reactants participating in the investigated reaction system are known, 
the respective values for Keq can be calculated (Alberty 1991). Values for standard Gibbs 
energies of formation fGi0 have been tabulated for a number of compounds (Alberty 2003). 
Computer programs are available with which one can calculate transformed standard Gibbs 
energies of formation (fGi’0) from fGi0 for a specified pH and ionic strength (Alberty 2003; 
Zamboni et al. 2008). In addition all possible dissociation forms of a compound are also 
lumped into a single reactant in fGi’0. The respective transformed Gibbs energy of 
formation for a reactant at a certain concentration (fGi’) is described by 
 fGi’ = fGi’0 + RT ln(ci)  (7) 
Applying fGi’ and fGi’0 instead of fGi and fGi0 in Equations (4) and (5) permit calculation 
of K’eq of a particular reaction. Large-scale thermodynamic studies for which availability of 
proper K’eqs are crucial often bemoan large uncertainties with which current 
thermodynamic data obtained from enzyme assays or based on Gibbs energies are afflicted 
and therefore not sufficient for data analysis.  
A way to circumvent these obstacles was introduced by (Canelas et al. 2011) who 
developed a new method to derive apparent equilibrium constants under real in vivo 
conditions. The basic idea of this work was based upon that the rate v of a certain reaction 
is directly dependent on the maximal turnover number Vmax, the kinetic properties () of 
the enzyme catalyzing this reaction and on the net flux state of the reaction in relation to 
the respective equilibrium (1-Q/K’eq). That is v = Vmax(1-Q/K’eq). S. cerevisiae was 
cultivated at 30°C in chemostats under aerobic conditions and glucose (7.5 g/L) as the 
sole carbon source in standard mineral medium at 32 different dilution rates spanning a 
wide range of specific growth rates (0.03 to 0.29 h-1) and as a consequence substrate 
conversion rates. Extracellular and intracellular metabolites were quantified at each 
dilution rate. Specific substrate and product fluxes given in mmol/gCDW/h were applied 
to a FBA based on a stoichiometric model and stoichiometric fluxes (v) for each reaction of 
the model network were calculated. Mass ratio coefficients Q of 27 network reactions 
were calculated from quantitative metabolite data at each v. From plots of Q vs. v the 
authors were able to extract values for K’eqs. It could be shown that Q of reactions 
operating close to the equilibrium state display a negative linear dependency of v. Values 
of K’eqs representing the thermodynamic equilibrium in the cell were determined by 
linear extrapolation to the y-axis (v = 0 and K’eq = Q) under the assumption that Vmax and 
kinetic properties of enzymes involved are not dependent on v. Intracellular K’eqs 
obtained differed in part significantly (up to a factor of 9) from their in vitro determined 
counterparts implying that reaction conditions in vivo (pH and ionic strength) deviate 
from that specified in in vitro assays or by the in silico approach. The big advantage of 
this approach is that in vivo K’eqs can be accurately determined without knowing 
anything about the intracellular pH and ionic strength. However only reactions located at 
or close to the equilibrium state are addressable.  
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Combining quantitative metabolomics data with thermodynamic rules on reactions 
constituting an operating metabolic network enables one to map reactions according to their 
location with respect to K’eq (Crabtree et al. 1997; Klimacek et al. 2010; Kümmel et al. 2006; 
Wang et al. 2004). That is close to or far away from equilibrium. A reaction reaches K’eq 
when the activity of an enzyme catalyzing a reaction downstream is low. On the other hand 
reactions located far away from K’eq are often catalyzed by enzymes that have regulatory 
functions in the cell or by flux limiting enzymes representing potential targets for strain 
improvement (Klimacek et al. 2010). Differently to the relative location of a particular 
reaction to its equilibrium, the sign (plus or minus) of rG’ or whether Q > or < K’eq gives 
important information about the direction of the reaction or of an entire pathway. 
Information about flux directions can be readily implemented as further restrictions into a 
stoichiometric network to increase reliability of flux distributions (Hoppe et al. 2007; 
Kümmel et al. 2006).  
3.2 Metabolic control analysis based on quantitative metabolomics in metabolic 
engineering of S. cerevisiae  
Identification of those reactions exerting significant control of flux through a particular 
pathway is crucial to develop strategies for flux improvement. As mentioned above 
reactions suspected in flux limitation can be elucidated elegantly by thermodynamic 
analysis. Once identified reactions can be further analyzed with respect to principles of 
MCA. The concept of MCA was developed and introduced by (Heinrich and Rapoport 1974; 
Kacser and Burns 1973) and is comprehensively described in (Stephanopoulos et al. 1998). 
MCA strictly applies only to steady-state conditions. To unravel whether the amount of 
enzyme or of a reactant participating in the reaction catalyzed by this enzyme contribute to 
flux limitation through this particular reaction two terms have been defined, namely the flux 
control coefficient (FCC) and the elasticity coefficient (). The FCC defines the relative 
change in the steady-state flux resulting from an infinitesimal change in the activity of an 
enzyme of the pathway divided by the relative change of the enzyme activity, represented 
by the relationship FCC = E dJ / (J dE), in which E and J stand for the concentration or 
activity of the enzyme and the steady-state flux, respectively. The  is intrinsically linked to 
the inherent enzyme kinetic properties and is defined by the ratio of the relative change in 
the reaction rate resulted by an infinitesimal change in the metabolite concentration and can 
be described by  = cj vi / (vi cj), where cj and vi represent the concentration of reactant j 
and the reaction rate of enzyme i. FCC and  are related by the flux-control connectivity 
theorem (Kacser and Burns 1973). 
 
1
0
j
L
J i
ci
i
FCC 

   (8) 
Equation (8) implies that large elasticities – concentration of reactant exerts large control on 
the enzyme reaction rate – are associated with small FCCs – the overall flux through the 
pathway is not very dependent on the enzyme activity – and vice versa. Consequently 
knowledge of either of these coefficient is only required. FCC can be determined by 
increasing the amount of active enzyme for example by expressing this particular enzyme at 
different expression levels and measuring the change in flux through the pathway. The level 
of enzyme present can be judged by determining its specific activity in cell-free extracts. If 
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the specific activity (µmol/mgprotein/min) for the isolated enzyme, the cellular protein 
content (mgprotein/gCDW) and the specific cell volume are known then the molar 
concentration of this enzyme can be calculated. Enzyme levels can be also determined by 
proteomics techniques and to some extent extrapolated from transcriptome data. 
Alternatively suitable antibodies that selectively bind to the target enzymes or fusion of an 
indicator peptide or protein tag to the enzyme to be analyzed permitting quantification 
either directly in vivo (GFP) or in vitro after separation of the target enzyme by affinity 
chromatography (e.g. His-tag, strep-tag) can be used for determining intracellular enzyme 
concentrations. If rate equations and associated kinetic parameters of all enzymes involved 
and at least their relative activity levels are known mathematical models can be applied to 
estimate FCCs and 's. Rate equations based on the steady-state or rapid equilibrium 
assumption for enzyme catalyzed reactions are comprehensively summarized in (Segel 
1993). However kinetic parameters typically used in this approach are determined by in 
vitro assays and it has been shown that in vitro generated data can significantly differ from 
those observed in vivo (Aragón and Sánchez 1985; Mauch et al. 2000; Reuss et al. 2007). This 
discrepancy is most likely due to the incomplete knowledge of the cellular composition and 
associated enzyme metabolite interactions as well as the difficulty to analyze enzymes under 
in vivo-like conditions at the lab bench. A promising step forward towards generation of 
more reliable in vivo-like in vitro enzyme kinetic data was reported recently (van Eunen et 
al. 2010). The authors suggested to measure enzyme activities in a buffered reaction mixture 
that simulates the intracellular cellular medium composition of S. cerevisiae.  
Using the non-linear lin-log formulation developed for metabolic network analysis by 
(Visser and Heijnen 2003) FCC and  can be estimated without any prior knowledge of 
enzyme-specific kinetic parameters (Visser and Heijnen 2002). In this approach the reaction 
rate is a nonlinear function of metabolite concentrations and is proportional to enzyme 
levels. lin-log kinetics is suited when large perturbations on the systems are analyzed. 
Furthermore statistical evaluation of parameter estimates is simplified (Wu et al. 2004). 
Nevertheless it is an approximation that fits to fundamental enzyme-reactant properties 
only in a certain range of perturbation (Wu et al. 2004).  
3.3 Substrate promiscuous enzymes  
Enzymes that have evolved relaxed or broad substrate specificity are substrate promiscuous 
(Hult and Berglund 2007). The presence of substrate promiscuous enzymes in a metabolic 
network considerably aggravates accurate network formulation and analysis if the accurate 
flux partition between the individual substrates is not known. This problem is further 
enhanced when the utilized substrates are highly connected within the network by other 
(substrate promiscuous) reactions. This is possibly best exemplified by the coenzyme 
promiscuous enzyme xylose reductase (XR) from Candida tenuis (Petschacher et al. 2005). To 
enable metabolic integration of xylose by S. cerevisiae XR and xylitol dehydrogenase XDH 
have to be integrated (Petschacher and Nidetzky 2008). Different to XDH which is strictly 
dependent on NAD(H) (Nidetzky et al. 2003), XR can oxidize both NADH and NADPH. 
These coenzymes in turn form the redox state of a cell and are important currency 
metabolites in all catabolic and anabolic pathways of the cell. Hence, keeping the redox state 
with respect to anabolism and catabolism balanced is crucial for the cell to stay alive. It was 
found based on stoichiometric considerations that the NADPH usage of XR is in strong 
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correlation with by-product formation in the form of xylitol, the reaction product of XR and 
the substrate of XDH in the subsequent reaction (van Maris et al. 2007). Usage of up to (0-
52)% NADPH by XR was compatible with a genome-scale metabolic network (Krahulec et 
al. 2010). Detailed kinetic analysis from in vitro studies showed that the XR almost 
exclusively utilizes NADPH in terms of catalytic efficiency (kcat/Km,coenzyme) and the 
selectivity parameter Rsel (kcat/(Ki,coenzymeKm,xylose)) which are widely used as marker 
parameter for coenzyme discrimination. Based on this data even a rough estimation of the 
coenzyme usage of XR in the cell is not possible. To solve the coenzyme usage riddle of XR 
we determined intracellular concentrations of NADH and NADPH (Klimacek et al. 2010) 
and integrated this information together with the relevant kinetic parameters (Petschacher 
et al. 2005) into the mechanistically appropriate enzyme kinetic rate expression (Banta et al. 
2002; Petschacher and Nidetzky 2005). A balanced coenzyme usage perfectly in line with 
physiology observed was obtained for the XR (Klimacek et al. 2010). Information about the 
correct flux partition of a particular substrate promiscuous enzyme can be implemented as 
further restrictions into a stoichiometric network to increase reliability of flux distributions. 
Furthermore this approach could be successfully applied on a series of wild-type and 
mutant forms of XR to predict reliably formation of xylitol (Krahulec et al. 2011).  
4. Conclusions 
Quantitative metabolomics is especially suited to help identifying key sites limiting an 
engineered metabolic route either within the created pathway but also apart from it. State-
of-the-art protocols for sample work-up and LC-MS and GC-MS analysis permit absolute 
quantification of metabolites from S. cerevisiae cells provided that a U-13C-labled IS is 
applied. Quantitative data in turn are indispensible for reliable pathway and network 
analysis in the form of a thermodynamic analysis, MCA or kinetic modelling. In 
combination with other omics techniques it represents a powerful tool to create designer 
microbial cell factories exposing improved or novel phenotypes. 
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